Pick's Disease  >>  LMTX (hydromethylthionine)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LMTX (hydromethylthionine) / TauRx
NCT01626378 / 2011-005529-34: Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)

Checkmark
Sep 2016 - Sep 2016: 
Checkmark
Jul 2016 - Jul 2016: 
Completed
3
220
US, Canada, Europe, RoW
TRx0237, Placebo
TauRx Therapeutics Ltd
Behavioral Variant Frontotemporal Dementia (bvFTD)
02/16
02/16

Download Options